Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence
Status:
Completed
Trial end date:
2017-07-12
Target enrollment:
Participant gender:
Summary
40 subjects with moderate-to-severe asthma will be randomly selected for study in which 20,
will be monitored for medication use (Dulera 100/5, Dulera 200/5 and Proventil HFA) over 3
months. These intervention subjects will receive medication use feedback at each visit, while
the control group will receive the standard of asthma care. Those interventional subjects
with Dulera adherence<60% will receive feedback based on an asthma adherence disease
management model protocol, Asthma Adherence Pathway. Intervention clinicians will been
trained in Motivational Interviewing to reduce subject ambivalence about medication use. The
primary hypothesis is that subjects who receive medication monitoring and Motivational
Interviewing adherence strategies will have better asthma control, as measured by the Asthma
Control Questionnaire, than the control group.
Phase:
Phase 4
Details
Lead Sponsor:
Asthma Management Systems
Collaborators:
Merck Sharp & Dohme Corp. West Penn Allegheny Health System
Treatments:
Formoterol Fumarate Mometasone Furoate Mometasone Furoate, Formoterol Fumarate Drug Combination